Keeping Current

Dec 10, 2025

Join the program for an in-depth discussion on low-grade glioma – from burden and diagnosis to therapies.

Credit available for this activity expires: 12/10/26
Earn Credit / Learning Objectives & Disclosures:

Dec 9, 2025

Join this program for relevant updates across the advanced and metastatic breast cancer (mBC) spectrum as presented in October 2025.

Credit available for this activity expires: 12/8/26
Earn Credit / Learning Objectives & Disclosures:

Dec 5, 2025

Where do oral selective estrogen receptor degraders (SERDs) fit in the overall landscape of first- and second-line advanced/metastatic breast cancer?

Credit available for this activity expires: 12/04/26
Earn Credit / Learning Objectives & Disclosures:

Dec 4, 2025

Preventing the first ASCVD is critically important. In this activity, we explore the evidence for early and intensive lipid lowering to significantly reduce patient’s cardiovascular (CV) risk.

Credit available for this activity expires: 12/05/26
Earn Credit / Learning Objectives & Disclosures:

Dec 2, 2025

Is your patient's proteinuria low enough? New KDIGO goals: target the immune cause and hit < 0.5 g/day to preserve kidney function.
 
Credit available for this activity expires: 12/2/2026
Earn Credit / Learning Objectives & Disclosures: